Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Erysipelas”

13 trials

Showing 13 of 13 results

Post-approval studies (Phase 4)Study completedNCT00295178
What this trial is testing

Study Comparing CUBICIN® (Daptomycin for Injection) With Vancomycin in Cellulitis or Erysipelas

Who this might be right for
Cellulitis
Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 80
Post-approval studies (Phase 4)Ended earlyNCT02032654
What this trial is testing

Duration of ANtibiotic Therapy for CEllulitis

Who this might be right for
CellulitisErysipelas
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 151
Not applicableLooking for participantsNCT05360914
What this trial is testing

Hospital at Home for Elderly Acute Ill Patients

Who this might be right for
CystitisErysipelasPneumonia
Defactum, Central Denmark Region 849
Testing effectiveness (Phase 2)WithdrawnNCT00893048
What this trial is testing

The Use of Oral Steroids in the Treatment of Cellulitis

Who this might be right for
CellulitisErysipelas
Milton S. Hershey Medical Center
Not applicableEnded earlyNCT02991131
What this trial is testing

Sivextro in Acute Bacterial Skin and Skin Structure Infection (ABSSSI) in Hospitalized Patients. A Global Observational Study

Who this might be right for
Skin Disease, Infectious
Bayer 108
Testing effectiveness (Phase 2)Study completedNCT02052388
What this trial is testing

Efficacy and Safety Study of Brilacidin to Treat Serious Skin Infections

Who this might be right for
Skin InfectionBacterial Infection
Cellceutix Corporation 215
Not applicableStudy completedNCT02902822
What this trial is testing

Tele-dermatology of Skin Cancer in a Cohort of Local Health Authority Employees in the Province of Bergamo

Who this might be right for
ErysipelasImpetigoHerpes Zoster+7 more
Centro Studi Gised 461
Post-approval studies (Phase 4)Not Yet RecruitingNCT07104552
What this trial is testing

Comparing Short to Standard Amoxicillin Course for Erysipelas

Who this might be right for
Erysipelas
Assistance Publique - Hôpitaux de Paris 656
Not applicableUnknownNCT03917277
What this trial is testing

Musculoskeletal Ultrasound of the Ankles in Erysipelas-like Erythema of Familial Mediterranean Fever

Who this might be right for
Erysipelas
Assistance Publique - Hôpitaux de Paris 15
Post-approval studies (Phase 4)Not Yet RecruitingNCT07549594
What this trial is testing

Prophylaxis of Recurrent Erysipelas in Lower Limbs: compreSsion thErapy vs aNTibiotics and Compression Therapy.

Who this might be right for
Recurrent Erysipelas
University Hospital, Tours 200
Post-approval studies (Phase 4)Ended earlyNCT01059123
What this trial is testing

Short Course of Amoxicillin for Erysipelas

Who this might be right for
Erysipelas
Assistance Publique - Hôpitaux de Paris 10
Post-approval studies (Phase 4)Study completedNCT00552799
What this trial is testing

RCT to Investigate if Prophylactic Antibiotics Prevent Further Episodes of Cellulitis (Erysipelas) of the Leg

Who this might be right for
Cellulitis/Erysipelas of the Leg
University of Nottingham 274
Testing effectiveness (Phase 2)Study completedNCT01519778
What this trial is testing

Safety and Exploratory Skin Lesion Measurement of TR-701 FA Study

Who this might be right for
Major Cutaneous AbscessCellulitisErysipelas
Trius Therapeutics LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 200

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation